We track LG Technology Ventures but have little verified detail yet.
At a glance
LG Technology Ventures appears in 2 funding rounds tracked by ValueAddVC since 2026. Its most recent tracked deal was BigHat Biosciences' $75M Series C round (Sep 24, 2026).
Portfolio
2 totalRecent Investment Activity
2Track record: led 0 and participated in 2 of 2 tracked venture rounds · 2 in the last 12 months
| Date | Company | Event | Role | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|---|---|
| Sep 24, 2026 | BigHat Biosciences | Series C | Participated | $75M | — | DFJ GrowthLeadPremji InvestLeadCatalio Capital ManagementLG Technology Ventures8VCAndreessen HorowitzEli Lilly and CompanyMerck Global Health Innovation FundQuadrille CapitalGRIDS CapitalIntermountain VenturesSection 32Sigmas GroupAmgen VenturesAlexandria Venture InvestmentsDiscovery Ventures | BioSpace |
| Aug 4, 2026 | Zenity | Series C | Participated | $125M | — | Pulse story |
Sector / Stage Activity
Co-Investors
12Value Add Research
Latest Pulse
- Sep 24, 2026BigHat Biosciences Raises $75M To Scale AI Antibody DesignBigHat Biosciences closed a $75 million Series C co-led by DFJ Growth and Premji Invest, taking total funding to $223 million as its AI-designed antibody-drug conjugate enters a Phase 1 trial for gastric cancer.→
- Aug 11, 2026AI Agent Security Funding Tops $435M in Two WeeksCorma, Zenity and Horizon3 raised a combined $435 million in the first ten days of August for AI-agent and AI-driven cybersecurity defense, three separate bets that defensive tooling is under-capitalized relative to offensive AI capability.→
- Aug 4, 2026Zenity Raises $125M to Police Enterprise AI AgentsNorwest led a $125M Series C for Zenity, which monitors and governs the AI agents enterprises are wiring into sensitive systems, bringing the New York- and Tel Aviv-based company's total funding to about $185M.→
- Jul 7, 2026FORE Biotherapeutics Raises $67.4M to Push BRAF Cancer DrugFORE Biotherapeutics closed an upsized $67.4 million Series D-2 extension, bringing its total Series D-2 to $110 million, to fund late-stage development of plixorafenib toward a targeted 2027 FDA submission for BRAF-mutated tumors.→
LG Technology Ventures FAQ
What companies has LG Technology Ventures invested in?
LG Technology Ventures' portfolio includes BigHat Biosciences, Zenity.
Who does LG Technology Ventures co-invest with most?
In the rounds Value Add tracks, LG Technology Ventures most often invests alongside 8VC (1 shared deal), Andreessen Horowitz (1 shared deal), Catalio Capital Management (1 shared deal), DFJ Growth (1 shared deal), Eli Lilly and Company (1 shared deal).
Sources & methodologyshow
- BusinessWireprimary source1 fact
- BioSpaceresearch database1 fact
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.